Croplan Biosciences Profile
Key Indicators
- Authorised Capital ₹ 0.20 M
as on 21-12-2024
- Paid Up Capital ₹ 0.10 M
as on 21-12-2024
- Company Age 14 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Revenue -4.35%
(FY 2020)
- Profit 65.83%
(FY 2020)
- Ebitda 72.02%
(FY 2020)
- Net Worth 58.09%
(FY 2020)
- Total Assets 30.94%
(FY 2020)
About Croplan Biosciences
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.20 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Sachin Pawar, Vishal Patil, and Suresh Jadhav serve as directors at the Company.
- CIN/LLPIN
U01403MH2010PTC201086
- Company No.
201086
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
20 Mar 2010
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Nashik, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Croplan Biosciences Private Limited offer?
Croplan Biosciences Private Limited offers a wide range of products and services, including Fertilizer, Micronutrient.
Who are the key members and board of directors at Croplan Biosciences?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vishal Patil  | Director | 20-Mar-2010 | Current |
| Sachin Pawar | Director | 20-Mar-2010 | Current |
| Suresh Jadhav | Director | 18-Oct-2017 | Current |
Financial Performance of Croplan Biosciences.
Croplan Biosciences Private Limited, for the financial year ended 2020, experienced Minor drop in revenue, with a 4.35% decrease. The company also saw a substantial improvement in profitability, with a 65.83% increase in profit. The company's net worth Soared by an impressive increase of 58.09%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Croplan Biosciences?
In 2019, Croplan Biosciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Haritpane Agro Farmer Producer Company LimitedActive 5 years 1 month
Sachin Pawar is a mutual person
- Tuljai Agro Services Farmers Producer Company LimitedActive 3 years 3 months
Sachin Pawar is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Croplan Biosciences?
Unlock and access historical data on people associated with Croplan Biosciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Croplan Biosciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Croplan Biosciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
